Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-04-06

Clinical Trial Update: SAL067 Treatment in Patients With Type 2 Diabetes Who Are Not Controlled by Metformin [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for SAL067 in patients with Type 2 diabetes not controlled by metformin has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SAL067

Snippet

Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd. | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED